An In Silico High Throughput Screening Strategy to Identify Putative Disease Modifying Agents for Chronic Neurological Disorders

Add to your list(s) Download to your calendar using vCal

• Professor Donald F. Weaver, University of Toronto
• Wednesday 02 March 2016, 14:15-15:15
• Department of Chemistry, Cambridge, Unilever lecture theatre.

If you have a question about this talk, please contact Lisa Masters.

Neurology is sometimes referred to as the “diagnose and adios” specialty, referring to the dearth of “curative” disease modifying drugs (DMDs) for the majority of major neurological disorders. Epilepsy and dementia are two of the most common neurological disorders. Although “symptomatic” agents are available, there are no DMDs for either of these disorders. In an attempt to identify agents, we created two in silico libraries for high throughput screening: the first (11.8 million entries) consists of commercially available organic molecules; the second consists of all molecules (MW

This talk is part of the Theory - Chemistry Research Interest Group series.

This talk is included in these lists:

• All Talks (aka the CURE list)
• Department of Chemistry
• Department of Chemistry, Cambridge, Unilever lecture theatre
• Featured lists
• Lennard-Jones Centre external
• School of Physical Sciences

Note that ex-directory lists are not shown.